Schedule 13G ownership disclosure
PharmaCyte Biotech, Inc.
Security class unavailable · CUSIP: 17512X203
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,231,482
- Percent of class
- 5.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-006702
- Form type
- SC 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- Feb 11, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership